Literature DB >> 28178712

Surgical Treatment for Leptomeningeal Disease.

Andrey A Volkov1, Andreas K Filis2, Frank D Vrionis3.   

Abstract

BACKGROUND: Advancements in cancer treatment have led to more cases of leptomeningeal disease, which requires a multimodal approach.
METHODS: Treatment modalities are reviewed from a neurosurgical standpoint, focusing on intrathecal chemotherapy and shunting devices. Potential complications and how to avoid them are discussed.
RESULTS: The Ommaya reservoir and the chemoport are used for administering intrathecal chemotherapy. Use of ventriculo-lumbar perfusion can efficiently deliver chemotherapeutic agents and improve intracerebral pressure. Shunting systems, in conjunction with all of their variations, address the challenge of hydrocephalus in leptomeningeal carcinomatosis. Misplaced catheters, malfunction of the system, and shunt-related infections are known complications of treatment.
CONCLUSIONS: From an oncological perspective, the surgical treatment for leptomeningeal disease is limited; however, neurosurgery can be used to aid in the administration of chemotherapy and address the issue of hydrocephalus. Minimizing surgical complications is important in this sensitive patient population.

Entities:  

Mesh:

Year:  2017        PMID: 28178712     DOI: 10.1177/107327481702400107

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  4 in total

Review 1.  Management of hydrocephalus in patients with leptomeningeal metastases: an ethical approach to decision-making.

Authors:  Nayan Lamba; Tim Fick; Rhishi Nandoe Tewarie; Marike L Broekman
Journal:  J Neurooncol       Date:  2018-07-18       Impact factor: 4.130

2.  Ventriculoperitoneal Shunts Equipped with On-Off Valves for Intraventricular Therapies in Patients with Communicating Hydrocephalus due to Leptomeningeal Metastases.

Authors:  Michael C Burger; Marlies Wagner; Kea Franz; Patrick N Harter; Oliver Bähr; Joachim P Steinbach; Christian Senft
Journal:  J Clin Med       Date:  2018-08-14       Impact factor: 4.241

Review 3.  Operative and peri-operative considerations in the management of brain metastasis.

Authors:  Eric W Sankey; Vadim Tsvankin; Matthew M Grabowski; Gautam Nayar; Kristen A Batich; Aida Risman; Cosette D Champion; April K S Salama; C Rory Goodwin; Peter E Fecci
Journal:  Cancer Med       Date:  2019-09-30       Impact factor: 4.452

4.  Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review.

Authors:  Leonor Fernandes; Leonor Vasconcelos de Matos; Débora Cardoso; Marlene Saraiva; Renata Medeiros-Mirra; Andreia Coelho; Helena Miranda; Ana Martins
Journal:  CNS Oncol       Date:  2020-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.